Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FR900359 |
Synonyms | |
Therapy Description |
FR900359 (UBO-QIC) inhibits GNA11 and GNAQ, potentially resulting in cell-cycle arrest, decreased proliferation, and increased differentiation of tumor cells (PMID: 30567972, PMID: 26658454, PMID: 32753482). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
FR900359 | UBO-QIC|FR 900359|FR-900359 | FR900359 (UBO-QIC) inhibits GNA11 and GNAQ, potentially resulting in cell-cycle arrest, decreased proliferation, and increased differentiation of tumor cells (PMID: 30567972, PMID: 26658454, PMID: 32753482). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|